These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21040498)

  • 1. Tissue specificity on insulin action and resistance: past to recent mechanisms.
    Benito M
    Acta Physiol (Oxf); 2011 Mar; 201(3):297-312. PubMed ID: 21040498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specificity of insulin action and resistance.
    Benito M
    Arch Physiol Biochem; 2011 Jul; 117(3):96-104. PubMed ID: 21506723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.
    Kido Y; Burks DJ; Withers D; Bruning JC; Kahn CR; White MF; Accili D
    J Clin Invest; 2000 Jan; 105(2):199-205. PubMed ID: 10642598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance.
    Valverde AM; Benito M; Lorenzo M
    Acta Physiol Scand; 2005 Jan; 183(1):59-73. PubMed ID: 15654920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
    Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
    J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate genes and late-onset type 2 diabetes mellitus. Susceptibility genes or common polymorphisms?
    Hansen L
    Dan Med Bull; 2003 Nov; 50(4):320-46. PubMed ID: 14694850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.
    Uysal KT; Wiesbrock SM; Marino MW; Hotamisligil GS
    Nature; 1997 Oct; 389(6651):610-4. PubMed ID: 9335502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue.
    Lauro D; Kido Y; Castle AL; Zarnowski MJ; Hayashi H; Ebina Y; Accili D
    Nat Genet; 1998 Nov; 20(3):294-8. PubMed ID: 9806552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes.
    Björnholm M; Zierath JR
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):354-7. PubMed ID: 15787605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: what can we learn from transgenic and knockout mice?
    Mauvais-Jarvis F; Kahn CR
    Diabetes Metab; 2000 Dec; 26(6):433-48. PubMed ID: 11173714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal integration and the specificity of insulin action.
    Kanzaki M; Pessin JE
    Cell Biochem Biophys; 2001; 35(2):191-209. PubMed ID: 11892791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A type IV P-type ATPase affects insulin-mediated glucose uptake in adipose tissue and skeletal muscle in mice.
    Dhar MS; Yuan JS; Elliott SB; Sommardahl C
    J Nutr Biochem; 2006 Dec; 17(12):811-20. PubMed ID: 16517145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance.
    Ruan H; Pownall HJ
    Curr Opin Investig Drugs; 2009 Apr; 10(4):346-52. PubMed ID: 19337955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in glucose transporter expression and function in diabetes: mechanisms for insulin resistance.
    Kahn BB
    J Cell Biochem; 1992 Feb; 48(2):122-8. PubMed ID: 1618926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity to adrenergic stimulation underlies the sexual dimorphism in the development of diabetes caused by Irs-2 deficiency.
    Garcia-Barrado MJ; Iglesias-Osma MC; Moreno-Viedma V; Pastor Mansilla MF; Gonzalez SS; Carretero J; Moratinos J; Burks DJ
    Biochem Pharmacol; 2011 Jan; 81(2):279-88. PubMed ID: 20959116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.